Wird geladen...
A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer
Cervical cancer is the fourth most common cancer in women worldwide. The current approaches still have limitations in predicting the therapy outcome of each individual because of cancer heterogeneity. The goal of this study was to establish a gene expression signature that could help when choosing t...
Gespeichert in:
| Veröffentlicht in: | Mol Ther Oncolytics |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Gene & Cell Therapy
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7530249/ https://ncbi.nlm.nih.gov/pubmed/33024818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.09.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|